Skip to content
Newsroom

Biodeal, on the record.

Press coverage, certifications, recognitions and company milestones — from the Piramal Alternatives investment to new accreditations and global partnerships.

Insights & news

Perspectives from India's CDMO frontier.

Expert perspectives on nasal spray drug delivery, injectable manufacturing, nutraceutical formulation, regulatory affairs and global export markets — alongside the latest Biodeal company news.

Filter
Nasal Spray Manufacturing

What is intranasal drug delivery? A complete guide

How nasal sprays deliver drugs through the nasal mucosa — formats, benefits and the manufacturing considerations that matter.

Nasal Spray Manufacturing

Metered-dose vs aqueous nasal sprays — which is right for your product?

A practical comparison of the two dominant nasal-spray formats, and how to choose the right one for your molecule.

Injectable CDMO

What is aseptic manufacturing in pharmaceuticals?

Inside the Grade A/B clean rooms, aseptic filling and controls behind reliable sterile injectable production.

Injectable CDMO

Lyophilisation in injectable manufacturing — what brands need to know

Why freeze-drying matters for stability, and what it means for your injectable development timeline.

Contract Manufacturing

How to choose a pharmaceutical CDMO in India

The credentials, capabilities and quality systems that separate a reliable CDMO partner from the rest.

Company News

₹110 Crore strategic investment from Piramal Alternatives

A landmark institutional investment to scale injectable capacity, strengthen our nasal spray leadership and expand export infrastructure.

R&D

Inside our DSIR-approved R&D centre

How our formulation, device and dossier teams take a molecule from concept to regulated-market launch.

Export & Global Markets

Navigating 56 export markets on a WHO-GMP passport

How WHO-GMP and PIC/S certification open regulated and semi-regulated markets across six global regions.

Regulatory & Compliance

Health Canada approval secured

A key regulated-market clearance that extends Biodeal's reach into North America and validates our quality systems.

Nutraceuticals

Ranked among India's Top 10 Nutraceutical CDMOs

Recognition of our nutraceutical contract-manufacturing depth across capsules, gummies, powders and effervescents.

Sept 2023Read article
Media & press

Working on a story?

For press enquiries, interviews, company facts or media assets, reach our communications team — we typically respond within 48 business hours.

Media enquiry Contact & officesinfo@biodealpharma.com · +91 120-6025048